{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:26:11Z","timestamp":1774261571518,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SIRIC BRIO","award":["INCa-DGOS-Inserm 6046"],"award-info":[{"award-number":["INCa-DGOS-Inserm 6046"]}]},{"name":"EORTC Cancer Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10549-018-4698-x","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T09:54:18Z","timestamp":1518429258000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994\/BIG-1-00 trial"],"prefix":"10.1007","volume":"169","author":[{"name":"on behalf of the EORTC 10994\/BIG 1-00 Study Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1088-2476","authenticated-orcid":false,"given":"Kim C.","family":"Aalders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Touati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tryfonidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myl\u00e8ne","family":"Annonay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Litiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9 R.","family":"Bonnefoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"4698_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnci\/dji021","volume":"97","author":"D Mauri","year":"2005","unstructured":"Mauri D, Pavlidis N, Ioannidis JPA (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97:188\u2013194. \n                    https:\/\/doi.org\/10.1093\/jnci\/dji021","journal-title":"J Natl Cancer Inst"},{"key":"4698_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrclinonc.2015.13","volume":"12","author":"K Tryfonidis","year":"2015","unstructured":"Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F (2015) Management of locally advanced breast cancer perspectives and future directions. Nat Rev Clin Oncol 12:147\u2013162","journal-title":"Nat Rev Clin Oncol"},{"key":"4698_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","volume":"15212","author":"N Wolmark","year":"2001","unstructured":"Wolmark N, Wang J, Mamounas E et al (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 15212:96\u2013102","journal-title":"J Natl Cancer Inst Monogr"},{"key":"4698_CR4","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","volume":"19","author":"JA Hage van der","year":"2001","unstructured":"van der Hage JA, van de Velde CJ, Julien JP et al (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19:4224\u20134237. \n                    https:\/\/doi.org\/10.1200\/jco.2001.19.22.4224","journal-title":"J Clin Oncol"},{"key":"4698_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384:164\u2013172. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(13)62422-8","journal-title":"Lancet"},{"key":"4698_CR6","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G Minckwitz von","year":"2012","unstructured":"von Minckwitz G, Untch M, Blohmer J-U et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30:1796\u20131804. \n                    https:\/\/doi.org\/10.1200\/jco.2011.38.8595","journal-title":"J Clin Oncol"},{"key":"4698_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/annonc\/mdu118","volume":"25","author":"H Bonnefoi","year":"2014","unstructured":"Bonnefoi H, Litiere S, Piccart M et al (2014) Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994\/BIG 1-00 phase III trial. Ann Oncol 25:1128\u20131136. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdu118","journal-title":"Ann Oncol"},{"key":"4698_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR et al (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26:1275\u20131281. \n                    https:\/\/doi.org\/10.1200\/jco.2007.14.4147","journal-title":"J Clin Oncol"},{"key":"4698_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/annonc\/mds248","volume":"24","author":"MV Dieci","year":"2013","unstructured":"Dieci MV, Barbieri E, Piacentini F et al (2013) Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-institution analysis. Ann Oncol 24:101\u2013108. \n                    https:\/\/doi.org\/10.1093\/annonc\/mds248","journal-title":"Ann Oncol"},{"key":"4698_CR10","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1200\/JCO.2011.37.2482","volume":"30","author":"LS Lindstr\u00f6m","year":"2012","unstructured":"Lindstr\u00f6m LS, Karlsson E, Wilking UM et al (2012) Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol 30:2601\u20132608. \n                    https:\/\/doi.org\/10.1200\/jco.2011.37.2482","journal-title":"J Clin Oncol"},{"key":"4698_CR11","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-16-2717","volume":"77","author":"JM Cejalvo","year":"2017","unstructured":"Cejalvo JM, Mart\u00ednez de Due\u00f1as E, Galv\u00e1n P et al (2017) Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer. Cancer Res 77:2213\u20132221. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-16-2717","journal-title":"Cancer Res"},{"key":"4698_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S1470-2045(11)70094-8","volume":"12","author":"HR Bonnefoi","year":"2011","unstructured":"Bonnefoi HR, Piccart-Gebhart MJ, Bogaerts J et al (2011) TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994\/BIG 1-00): a randomised phase 3 trial. Lancet Oncol 12:527\u2013539. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(11)70094-8","journal-title":"Lancet Oncol"},{"key":"4698_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 22:1736\u20131747. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdr304","journal-title":"Ann Oncol"},{"key":"4698_CR14","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1078-0432.CCR-06-2659","volume":"13","author":"D Palmieri","year":"2007","unstructured":"Palmieri D, Chambers AF, Felding-Habermann B et al (2007) The biology of metastasis to a sanctuary site. Clin Cancer Res 13:1656\u20131662. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-2659","journal-title":"Clin Cancer Res"},{"key":"4698_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0388-4","author":"K Pogoda","year":"2013","unstructured":"Pogoda K, Niwi\u0144ska A, Murawska M, Pie\u0144kowski T (2013) Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Med Oncol. \n                    https:\/\/doi.org\/10.1007\/s12032-012-0388-4","journal-title":"Med Oncol"},{"key":"4698_CR16","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/cncr.23930","volume":"113","author":"NU Lin","year":"2008","unstructured":"Lin NU, Claus E, Sohl J et al (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer. Cancer 113:2638\u20132645. \n                    https:\/\/doi.org\/10.1002\/cncr.23930","journal-title":"Cancer"},{"key":"4698_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/sj.bjc.6601198","volume":"89","author":"JJ James","year":"2003","unstructured":"James JJ, Evans AJ, Pinder SE et al (2003) Bone metastases from breast carcinoma: histopathological\u2014radiological correlations and prognostic features. Br J Cancer 89:660\u2013665. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6601198","journal-title":"Br J Cancer"},{"key":"4698_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10549-015-3341-3","volume":"150","author":"K Kast","year":"2015","unstructured":"Kast K, Link T, Friedrich K et al (2015) Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat 150:621\u2013629. \n                    https:\/\/doi.org\/10.1007\/s10549-015-3341-3","journal-title":"Breast Cancer Res Treat"},{"key":"4698_CR19","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1158\/0008-5472.SABCS-09-6032","volume":"69","author":"Y Park","year":"2009","unstructured":"Park Y, Chang M, Lee S, Kim S, Cho E, Choi Y, Ok O, Baek H, Lee J, Nam S, Yang J (2009) Heterogeneity of Triple Negative Breast Cancer (TNBC): TNBC might be divided into two or more subgroups by clinicopathologic findings. Cancer Res 69:6032","journal-title":"Cancer Res"},{"key":"4698_CR20","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1200\/JCO.2012.46.1574","volume":"31","author":"O Metzger-Filho","year":"2013","unstructured":"Metzger-Filho O, Sun Z, Viale G et al (2013) Patterns of recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol 31:3083\u20133090. \n                    https:\/\/doi.org\/10.1200\/jco.2012.46.1574","journal-title":"J Clin Oncol"},{"key":"4698_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10549-015-3390-7","volume":"151","author":"Y Lee","year":"2015","unstructured":"Lee Y, Kang E, Lee AS et al (2015) Outcomes and recurrence patterns according to breast cancer subtypes in Korean women. Breast Cancer Res Treat 151:183\u2013190. \n                    https:\/\/doi.org\/10.1007\/s10549-015-3390-7","journal-title":"Breast Cancer Res Treat"},{"key":"4698_CR22","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R et al (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271\u20133277. \n                    https:\/\/doi.org\/10.1200\/jco.2009.25.9820","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4698-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T20:28:35Z","timestamp":1549916915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4698-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4698"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4698-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}